Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Oligodendroglioma 1Neoplasms 1Neoplasm Metastasis 1Gliosarcoma 1Glioma 1Glioblastoma 1Ependymoma 1Brain Neoplasms 1Astrocytoma 1

Interventions

Temozolomide 7Magnetic Resonance Spectroscopy 7X-Rays 5Phantoms, Imaging 5Bevacizumab 5Specimen Handling 4Nuclear Medicine Department, Hospital 4Carboplatin 3Biopsy 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2olaparib 2larotrectinib 2ivosidenib 2erdafitinib 2Vemurafenib 2Lapatinib 2LY3023414 2Everolimus 2Etoposide 2Erlotinib Hydrochloride 2veliparib 1pomalidomide 1poly ICLC 1picropodophyllin 1marizomib 1imetelstat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Ependymoma × Ritonavir × Clear all
NCT01095094 2013-06-10

Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma

Case Comprehensive Cancer Center

Phase 2 Terminated
19 enrolled 9 charts
CNSSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡